Abstract

PROGRAM PLANNING AND EVALUATION The Leadership of the BCMGC has sought advice and input from a broad range of internal and external experts to help guide the development of the Center since its inception in Fall of 2002. While the composition of our External Advisory Board has remained the same, the structure and roles of our internal advisory committees have been reevaluated and improved to better serve the future needs of the Cancer Center. A Cancer Strategic Planning Committee was convened by President Traber as part of a comprehensive college strategic planning process shortly after his arrival to BCM. Several other committees addressed other aspects of the College mission and goals. The Cancer Committee, chaired by Dr. Osborne even before he was asked to serve as Director, recommended further development of the Cancer Center with a goal of achieving NCI designation. The Committee also recommended the creation of Cancer Center clinical and laboratory space as well as research program enhancement and new program development through recruitment of at least 50 new faculty, clinical and basic, over the next 5 years. The recommendations of this planning committee have been or are now being implemented, culminating in the submission of this CCSG.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA125123-03
Application #
7900423
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
3
Fiscal Year
2009
Total Cost
$54,834
Indirect Cost

  Institution

Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030

  Publications

Gibbons, Don L; Creighton, Chad J (2018) Pan-cancer survey of epithelial-mesenchymal transition markers across the Cancer Genome Atlas. Dev Dyn 247:555-564
Matsunuma, Ryoichi; Chan, Doug W; Kim, Beom-Jun et al. (2018) DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer. Proc Natl Acad Sci U S A 115:E11978-E11987
McClard, Cynthia K; Kochukov, Mikhail Y; Herman, Isabella et al. (2018) POU6f1 Mediates Neuropeptide-Dependent Plasticity in the Adult Brain. J Neurosci 38:1443-1461
Hogstad, Brandon; Berres, Marie-Luise; Chakraborty, Rikhia et al. (2018) RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions. J Exp Med 215:319-336
Amirian, E Susan; Ostrom, Quinn T; Armstrong, Georgina N et al. (2018) Aspirin, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and Glioma Risk: Original Data from the Glioma International Case-Control Study and a Meta-Analysis. Cancer Epidemiol Biomarkers Prev :
Mishra, Prachi; Tang, Wei; Putluri, Vasanta et al. (2018) ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming. J Clin Invest 128:323-340
Piyarathna, Danthasinghe Waduge Badrajee; Rajendiran, Thekkelnaycke M; Putluri, Vasanta et al. (2018) Distinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder. Eur Urol Focus 4:907-915
Criglar, Jeanette M; Anish, Ramakrishnan; Hu, Liya et al. (2018) Phosphorylation cascade regulates the formation and maturation of rotaviral replication factories. Proc Natl Acad Sci U S A 115:E12015-E12023
Rimawi, Mothaffar F; De Angelis, Carmine; Contreras, Alejandro et al. (2018) Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer. Breast Cancer Res Treat 167:731-740
Ostrom, Quinn T; Kinnersley, Ben; Armstrong, Georgina et al. (2018) Age-specific genome-wide association study in glioblastoma identifies increased proportion of 'lower grade glioma'-like features associated with younger age. Int J Cancer 143:2359-2366

Showing the most recent 10 out of 991 publications